Inhibition of platelet aggregation by prostaglandin E1 (PGE1) in diabetic patients during therapy with clopidogrel and aspirin

Diabetes mellitus (DM) is associated with increased platelet activation and reduced platelet inhibition by clopidogrel. Prostaglandin E1 (PGE1) stimulates adenyl cyclase activity in platelets and increases cyclic AMP concentrations, which inhibit Ca(2+)release and platelet aggregation induced by P2Y...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: KREUTZ, ROLF P., NYSTROM, PERRY, KREUTZ, YVONNE, MIAO, JIA, KOVACS, RICHARD, DESTA, ZERUESENAY, FLOCKHART, DAVID A., JIN, YAN
Format: Artigo
Jezik:Inglês
Izdano: 2012
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4028123/
https://ncbi.nlm.nih.gov/pubmed/22385219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/09537104.2012.661107
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items